Perbak Capital Partners »

Supernus Pharmaceuticals shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $349k 6.8k 51.69

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr State Street Ind (XLI)
Select Sector Spdr Tr State Street Con (XLY)
Select Sector Spdr Tr State Street Con (XLP)
Vaneck Etf Trust Oil Services Etf (OIH)
Spdr Series Trust State Street Spd (KIE)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Real Estate Etf (VNQ)
Select Sector Spdr Tr State Street Mat (XLB)
Select Sector Spdr Tr State Street Hea (XLV)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
Ishares Tr Ishares Semicdtr (SOXX)
Draftkings Com Cl A (DKNG)
Spdr Series Trust State Street Spd (XHB)
Northrop Grumman Corporation (NOC)

View all positions for Perbak Capital Partners

Top funds holding Supernus Pharmaceuticals

BlackRock
Millennium Management
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Nomura Asset Management International
Armistice Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Loomis, Sayles and
Stephens Investment Management Group
Point72 Asset Management
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals